These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28344144)

  • 1. Patient-Specific Tailored Intervention Improves INR Time in Therapeutic Range and INR Variability in Heart Failure Patients.
    Gotsman I; Ezra O; Hirsh Raccah B; Admon D; Lotan C; Dekeyser Ganz F
    Am J Med; 2017 Aug; 130(8):982-989. PubMed ID: 28344144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
    Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A
    Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Validation of R-T Estimation for CoaguChek XS INR Results.
    Richter C; Taylor J; Wright J; Fletcher B
    Ann Pharmacother; 2016 Aug; 50(8):645-8. PubMed ID: 27199494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader E; Martin N; Cohen G; Meyer M; Reiter P; Dimova A; Parikh D
    J Clin Pharm Ther; 2012 Aug; 37(4):375-7. PubMed ID: 22171554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.
    Løkkegaard T; Pedersen TH; Lind B; Siersma V; Waldorff FB
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R; Figueroa Guerrero CA; Mainar de Paz V; Arribas García MP; Sánchez Perruca L; Rodríguez Barrientos R; Casado López M; Pedraza Flechas AM
    Med Clin (Barc); 2015 Sep; 145(5):192-7. PubMed ID: 25433789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
    Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
    Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9 Polymorphism and Unstable Anticoagulation with Warfarin in Patients Within the First 3 Months Following Heart Valve Replacement.
    Wypasek E; Cieśla M; Suder B; Janik Ł; Sadowski J; Undas A
    Adv Clin Exp Med; 2015; 24(4):607-14. PubMed ID: 26469104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
    Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.